The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs SD Grosse, RE Nelson, KA Nyarko, LC Richardson, GE Raskob Thrombosis research 137, 3-10, 2016 | 478 | 2016 |
Multidrug-resistant bacterial infections in US hospitalized patients, 2012–2017 JA Jernigan, KM Hatfield, H Wolford, RE Nelson, B Olubajo, SC Reddy, ... New England Journal of Medicine 382 (14), 1309-1319, 2020 | 467 | 2020 |
The clinical epidemiology of male osteoporosis: a review of the recent literature T Willson, SD Nelson, J Newbold, RE Nelson, J LaFleur Clinical epidemiology, 65-76, 2015 | 275 | 2015 |
National estimates of healthcare costs associated with multidrug-resistant bacterial infections among hospitalized patients in the United States RE Nelson, KM Hatfield, H Wolford, MH Samore, RD Scott, SC Reddy, ... Clinical Infectious Diseases 72 (Supplement_1), S17-S26, 2021 | 253 | 2021 |
The cost-effectiveness of telestroke in the treatment of acute ischemic stroke RE Nelson, GM Saltzman, EJ Skalabrin, BM Demaerschalk, JJ Majersik Neurology 77 (17), 1590-1598, 2011 | 220 | 2011 |
Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections V Stevens, K Geiger, C Concannon, RE Nelson, J Brown, G Dumyati Clinical Microbiology and Infection 20 (5), O318-O324, 2014 | 218 | 2014 |
Incidence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella infections in the United States: a systematic literature review J McDanel, M Schweizer, V Crabb, R Nelson, M Samore, K Khader, ... infection control & hospital epidemiology 38 (10), 1209-1215, 2017 | 191 | 2017 |
Costs and infant outcomes after implementation of a care process model for febrile infants CL Byington, CC Reynolds, K Korgenski, X Sheng, KJ Valentine, ... Pediatrics 130 (1), e16-e24, 2012 | 189 | 2012 |
Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridium difficile infection VW Stevens, RE Nelson, EM Schwab-Daugherty, K Khader, MM Jones, ... JAMA internal medicine 177 (4), 546-553, 2017 | 178 | 2017 |
Cost-effectiveness of sacubitril-valsartan combination therapy compared with enalapril for the treatment of heart failure with reduced ejection fraction JB King, RU Shah, AP Bress, RE Nelson, BK Bellows JACC: Heart Failure 4 (5), 392-402, 2016 | 145 | 2016 |
Mortality, length of stay, and healthcare costs associated with multidrug-resistant bacterial infections among elderly hospitalized patients in the United States RE Nelson, D Hyun, A Jezek, MH Samore Clinical Infectious Diseases 74 (6), 1070-1080, 2022 | 134 | 2022 |
Incidence and outcomes associated with infections caused by vancomycin-resistant enterococci in the United States: systematic literature review and meta-analysis HY Chiang, EN Perencevich, R Nair, RE Nelson, M Samore, K Khader, ... infection control & hospital epidemiology 38 (2), 203-215, 2017 | 126 | 2017 |
Incidence and outcomes associated with Clostridium difficile infections: a systematic review and meta-analysis AR Marra, EN Perencevich, RE Nelson, M Samore, K Khader, HY Chiang, ... JAMA Network Open 3 (1), e1917597-e1917597, 2020 | 124 | 2020 |
Testing the fetal origins hypothesis in a developing country: evidence from the 1918 influenza pandemic RE Nelson Health economics 19 (10), 1181-1192, 2010 | 124 | 2010 |
A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States DJ Livorsi, ML Chorazy, ML Schweizer, EC Balkenende, AE Blevins, ... Antimicrobial Resistance & Infection Control 7, 1-9, 2018 | 119 | 2018 |
Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations DI Brixner, KC Jackson, II, X Sheng, RE Nelson, A Keskinaslan Current medical research and opinion 24 (9), 2597-2607, 2008 | 100 | 2008 |
Cost-Effectiveness Analysis of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection RU Varier, E Biltaji, KJ Smith, MS Roberts, MK Jensen, J LaFleur, ... infection control & hospital epidemiology 36 (4), 438-444, 2015 | 95 | 2015 |
Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia BE Jones, J Ying, V Stevens, C Haroldsen, T He, MK Nevers, ... JAMA Internal Medicine 180 (4), 552-560, 2020 | 80 | 2020 |
Attributable mortality of healthcare-associated infections due to multidrug-resistant gram-negative bacteria and methicillin-resistant Staphylococcus aureus RE Nelson, RB Slayton, VW Stevens, MM Jones, K Khader, MA Rubin, ... infection control & hospital epidemiology 38 (7), 848-856, 2017 | 78 | 2017 |
Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection RU Varier, E Biltaji, KJ Smith, MS Roberts, MK Jensen, J LaFleur, ... Clinical Microbiology and Infection 20 (12), 1343-1351, 2014 | 72 | 2014 |